Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scancell
Biotech
Genmab buys 2nd antibody from Scancell in deal worth up to $630M
Scancell can earn up to $630 million from the new sale if Genmab spins the antibody into drug products across all defined modalities.
Darren Incorvaia
Dec 4, 2024 11:55am
Scancell enjoys stock bounce on back of cancer vaccine data
Sep 19, 2023 10:55am
Immunocore lifer leaves to head research at TCR rival Scancell
Jan 21, 2019 7:59am
After $270M round, BioNTech pens TCR pact with Scancell
Jan 9, 2018 10:30am
EuroBiotech: More Articles of Note
May 11, 2017 9:19am
Scancell taps lung cancer nonprofit for trial recruitment
Jan 30, 2017 8:43am